This study revealed that NKG2D induction on CD8+T cells serves as an important mechanism for Dox-augmented IL-12–mediated tumor growth inhibition because the increased NKG2D expression on CD8+T cells plays a role in tumor-specific localization (Figures 3 and 5). This evidence concerns the gene CD8A and neoplasm.